[Capital Cube] Owens & Minor Inc (NYSE:OMI)(TREND ANALYSIS) With respect to peers, relative outperformance over the last year is in contrast to the more recent underperformance.
Owens & Minor, Inc. trades at a lower Price/Book multiple (2.31) than its peer median (3.61).
The market expects OMI-US‘s earnings to grow at about the same rate as its chosen peers and also does not seem to expect much improvement in its below peer median returns.
OMI-US‘s median net profit margins and relatively high asset efficiency give it some operating leverage.
Changes in annual earnings (relative to peers) are better than the change in its revenues (relative to peers), implying the company is focused more on earnings.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
Owens & Minor Inc (NYSE:OMI) stock is currently trading 10.61% below its 52-week-high, 16.27% above its 52-week-low. The 1-year stock price history is in the range of $31.89 – $41.48. Owens & Minor Inc (OMI) has a price to earnings ratio of 22.47 versus Services sector average of 20.03. OMI stock price has outperformed the S&P 500 by 0.9%. The Medical-Wholesale Drug Distribution company is currently valued at $2.32 billion, and its share price closed the last trading session at $37.08. The stock has a 50-day moving average of $39.89 and a 200-day moving average of $37.15.
Owens & Minor Inc (OMI) current short interest stands at 8.35 million shares. It has decreased by 8% from the same period of last month. Around 8% of the company’s shares, which are float, are short sold. With a 10-days average volume of 0.84 million shares, the number of days required to cover the short positions stand at 10 days.
OMI is forecasted to report earnings per share of $0.48 and a revenue of $2.43 billion for the 1st Quarter of the fiscal year 2016. Owens & Minor Inc (OMI) expects to post results on May 03. The Medical-Wholesale Drug Distribution company announced last quarter earnings per share of $0.56 against a consensus Street estimate of $0.49, beating the average estimate by $0.07. The company posted a revenue of $2.49 billion compared to an estimation of $2.51 billion.
Is this a Trading Opportunity? Click here for a free Trend Analysis Report
There are currently nine analysts that cover Owens & Minor Inc stock. Of those nine, six have a Hold rating and three have a Sell rating. On a consensus basis this yields to an Underweight rating. The consensus target price stands at $34.75.
A recent analyst activity consisted of Baird downgrading their Neutral rating to Underperform on April 21. Baird decreased price target from $36 to $32. This corresponds to a 13.7% downside from the last closing price. On the date of report, the stock closed at $36.48.
Credit Suisse initiated their coverage on the stock with Underperform rating on March 15, and fixed their price target at $36. This corresponds to a 2.91% downside from the last closing price. On the date of report, the stock closed at $39.93.
Company snapshot
Owens & Minor, Inc. distributes medical/surgical supplies throughout the United States. The Company’s customers include hospitals, integrated healthcare systems, and group purchasing organizations. Owens & Minor also provides services in supply chain management, logistics, and technology.
The post Is Owens & Minor Inc (NYSE:OMI) Well Tailored for Your Portfolio? appeared first on Street Report.